News & Perspective

Jan 08, 2018

Jan 08, 2018

News Scan for Jan 08, 2018

Saudi MERS cases
Next-gen flu vaccine grant
New H5N6 infection
Yellow fever in Nigeria
Salmonella in Europe

Dec 05, 2017

Dec 05, 2017

Flu Scan for Dec 05, 2017

WHO pandemic flu guidance
H5N6 reassortant in Taiwan

Jul 27, 2017

Jul 27, 2017

News Scan for Jul 27, 2017

Saudi MERS case
Public health funding threat
Hepatitis battle snapshot
Global flu vaccine uptake

Dec 10, 2015

Dec 10, 2015

Avian Flu Scan for Dec 10, 2015

H7N9 prime-boost vaccine
More H5N2, H5N9 in France

Jul 23, 2015

Jul 23, 2015

News Scan for Jul 23, 2015

MERS in Saudi Arabia
H5N2 vaccine in chickens
Experimental Marburg drug
Klebsiella in retail meat
Epidemic threat poll
EV-D68 rapid test

Jul 13, 2011

Jul 13, 2011

Study: Adjuvanted H1N1 vaccines had little effect on GBS risk

(CIDRAP News) – A five-country study from Europe indicates that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barre syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»